CARLY SEALY: Open Payments
NPI 1831706589 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,904 in 101 payments from 24 companies in 2025. Trend: 2023 $779 · 2024 $1,032 · 2025 $1,904
Food & beverage: $1,820Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $492 |
| Janssen Biotech, Inc. | 20 | $399 |
| Ardelyx, Inc. | 18 | $242 |
| Madrigal Pharmaceuticals | 5 | $109 |
| Celltrion USA Inc. | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| Intercept Pharmaceuticals, Inc. | 2 | $50 |
| QOL Medical, LLC | 2 | $49 |
| Lilly USA, LLC | 2 | $38 |
Products named: TREMFYA, IBSRELA, RINVOQ, MAVYRET, REZDIFFRA, VEGZELMA, ENTYVIO, CREON.
Industry payments across SC — which companies pay providers there.
